logo
Select company
Select metric
72.82%Capital Expenditures Margin
VS
Market
5
Sector
5
Industry
11
History
27
$ 2.23Close
$ 1.1 - $ 5.94 52-Week Range
Ticker Information

Ticker

TCRX

Company Name

TSCAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TSCAN THERAPEUTICS INC - Capital Expenditures Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TCRX - CapEx % Historical data
DateCapital ExpenditureCapital Expenditures MarginRevenues
6/30/2025$ 5.07M72.82%$ 6.96M
3/31/2025$ 4.65M105.23%$ 4.42M
12/31/2024$ 3.83M135.83%$ 2.82M
9/30/2024$ 3.41M36.38%$ 9.36M
6/30/2024$ 3.46M28.32%$ 12.2M
3/31/2024$ 3.01M20.34%$ 14.81M
12/31/2023$ 3.15M14.95%$ 21.05M
9/30/2023$ 4.05M23.94%$ 16.93M
6/30/2023$ 3.06M18.64%$ 16.41M
3/31/2023$ 4.53M26.17%$ 17.32M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TSCAN THERAPEUTICS INC's latest trailing twelve months (TTM) CapEx % stands at 390.6%.
  • Over the past 5 years, TSCAN THERAPEUTICS INC's average CapEx % has been 72.03%.
  • The median CapEx % for TSCAN THERAPEUTICS INC during this period was 37.22%
  • TSCAN THERAPEUTICS INC reached its highest CapEx % over the past 5 years at 390.6%.
  • The lowest CapEx % recorded by TSCAN THERAPEUTICS INC in the same timeframe 14.95%

TSCAN THERAPEUTICS INC's CapEx % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx % Benchmarks
CompanyCapEx %
CRVO : CERVOMED INC -FATE : FATE THERAPEUTICS INC 35.76%OVID : OVID THERAPEUTICS INC 0.27%ARMP : ARMATA PHARMACEUTICALS INC 12.14%CBUS : CIBUS INC 16.41%CUE : CUE BIOPHARMA INC 0.97%VERU : VERU INC 0.96%SRZN : SURROZEN INC 0.6%PSTV : PLUS THERAPEUTICS INC 0.09%KRRO : KORRO BIO INC 104.9%

Definition of Capital Expenditures Margin

[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
CapEx / Revenues
(=) CapEx %
CapEx % for TSCAN THERAPEUTICS INC is calculated as follows: CapEx [ $ 4.24M ] / Revenues [ $ 1.08M ]
(=) CapEx % [ 390.6% ]

TCRX - Capital Expenditures Margin, Last 5 years

14.95%

Minimum

Dec 31, 2023

390.6%

Maximum

Dec 31, 2020

72.03%

Average

37.22%

Median

CapEx % Benchmark Analysis

The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.46% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
filtered constituents2.85K
min0%
max15.04%
average3.46%
median2.43%
std3.27%